Episode Details

Back to Episodes
516:  Illuminating the Science for All to See  | Usama Malik, CFO, Immunomedics

516: Illuminating the Science for All to See | Usama Malik, CFO, Immunomedics

Published 6 years, 5 months ago
Description

“It’s the economics, the finance,” says CFO Usama Malik, who quickly adds the words “and the accounting” to his short list of finance leader action items. Malik begins where most CFOs end–with the economics behind the business model. Everything else follows, he explains.  

“This role is about applying a broader lens to an entire industry and figuring out a competitive advantage,” adds Malik, who, while bullish on the science behind Immunomedics’ future offerings, makes clear his contention that it’s the economics that will ultimately determine the company’s fate.

“Historically, there have been fund-raising CFOs, operational CFOs, and strategic CFOs. … I’ve now started to combine these disciplines, and the culmination of these is really advancing the role,” explains Malik. –Jack Sweeney   

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us